VATS Lobectomy Is Associated With Greater Recurrence-Free Survival Than SBRT for Clinical Stage I Lung Cancer

Thursday, December 14, 2017

Submitted by

Source

Source Name: Journal of Thoracic and Cardiovascular Surgery

Source URL: http://www.jtcvsonline.org/article/S0022-5223(17)31718-X/fulltext

Author(s)

Lorraine D. Cornwell, Alfredo E. Echeverria, Jason Samuelian, Jessica Mayor, Roberto F. Casal, Faisal G. Bakaeen, Shuab Omer, Ourania Preventza, Weiyuan Mai, George Chen, Katherine H. Simpson, Drew Moghanaki, Angela W. Zhu

Using propensity score matching, patients with clinical stage I NSCLC who underwent either VATS lobectomy or stereotactic body radiotherapy (SBRT) were compared for long-term outcomes. Among 37 matched pairs, tumor control at 3 years was twice as good for surgery (p=.0038), cancer-specific survival was 15 percentage points better for surgery (p=.055), and overall survival and recurrence-free survival were superior for surgery (p<.005 for both). SBRT was an independent predictor of recurrence and poorer survival .